查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933351

全球抗生物膜製劑市場：市場規模、佔有率、成長率、產業分析、類型、應用和地區因素及未來預測（2026-2034）

Anti-Biofilm Agents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 請詢問到貨日

價格

抗生物膜製劑市場成長因素

受急性和慢性傷口日益增多以及生物膜相關感染負擔加重的推動，全球抗生物膜製劑市場正經歷穩定成長。根據 Fortune Business Insights 的一項研究顯示，2025 年全球抗生物膜製劑市場規模將達到 15 億美元。預計該市場將從 2026 年的 16.4 億美元成長到 2034 年的 32.1 億美元，預測期內複合年增長率 (CAGR) 為 8.79%。北美地區憑藉先進的傷口護理基礎設施和對生物膜管理的高度重視，在 2025 年將以 36.49% 的市場佔有率領先。

抗生物膜製劑是旨在預防、破壞和控制生物膜的產品。生物膜是由微生物在其自身產生的基質內所形成的結構化菌落。生物膜常見於慢性傷口，並透過增加對抗生素和免疫反應的抗藥性而顯著延緩傷口癒合。根據MDPI 2024年的數據，約60%的慢性傷口和約10%的急性傷口會形成生物膜，這凸顯了臨床上對有效抗生物膜解決方案日益增長的需求。

市場動態

市場驅動因素

急性和慢性傷口數量的增加是市場成長的主要驅動因素。糖尿病足潰瘍、壓瘡、靜脈性腿部潰瘍、手術傷口和燒傷等病症被認為是生物膜形成的高風險區域。 例如，根據美國國家生物技術資訊中心 (NCBI) 2023 年的數據，全球糖尿病足潰瘍的盛行率約為 6.3%。此外，醫院獲得性壓瘡仍然令人擔憂，據估計，英國住院患者的壓瘡發生率為 8.7%。這些趨勢正在推動對先進傷口護理和抗生物膜產品的需求。

市場限制因子

發展中國家的診斷和治療率低，限制了市場成長。轉診延遲、缺乏臨床專業知識、缺乏認知以及缺乏標準化指南，常常促使慢性傷口診斷延遲。 2023 年發表的一項研究報告稱，糖尿病足潰瘍患者從症狀出現到接受專科醫生評估的平均延遲時間為 15 至 126 天。這些延遲阻礙了抗生物膜藥物的及時應用，尤其是在印度、中國和巴西等新興市場。

市場機會

各大公司研發投入的增加帶來了巨大的成長機會。各公司正大力投資臨床試驗和產品創新，以開發具有增強抗生物膜性能的先進敷料、凝膠和粉末。例如，2024年5月，康維特公司報告其AQUACEL Ag+Extra敷料在治療靜脈性腿部潰瘍方面取得了積極的臨床結果。政府主導的傷口護理意識提升計畫的增加，也進一步推動了市場擴張。

市場挑戰

生物膜預防和控制指南的執行情況不佳仍然是一個挑戰，尤其是在發展中地區。醫護人員和患者缺乏相關意識促使傷口照護不足，進一步加劇了生物膜的傳播。此外，先進抗生物膜產品的高昂成本限制了其在註重成本的醫療系統中的應用。

抗生物膜市場趨勢

新型抗生物膜產品的推出是市場的主要趨勢。研究人員正在積極探索奈米技術、奈米藥物遞送系統以及抗菌奈米顆粒（例如銀和氧化鋅），以提高生物膜的滲透性和破壞性。評估這些先進技術的臨床試驗預計將在預測期內提高產品療效並推動市場需求。

細分市場分析

依產品類型劃分，敷料將在2026年佔市場主導地位，市佔率達67.86%。這主要歸功於敷料在預防細菌污染和控制生物膜方面的有效性。

依分子類型劃分，銀類產品將在2026年佔市場主導地位，市佔率達47.62%。這主要歸功於銀的廣譜抗菌活性。

依傷口類型劃分，慢性傷口將在2026年佔68.15%的市場。這主要受糖尿病足潰瘍和壓瘡高發生率的驅動。

依最終用戶劃分，醫院將在2026年佔43.12%的市場佔有率，成為市場主導力量，這反映了醫院較高的住院率以及獲得先進傷口護理解決方案的機會。

區域展望

北美預計將引領市場，在強勁的醫療保健支出和產品創新推動下，2025年市場規模將達到5.5億美元，2026年將達到5.9億美元。

歐洲預計將保持穩定成長，這得益於其完善的醫療保健體系和不斷提高的健康意識。

亞太地區預計將實現最快的成長速度，這主要受傷口盛行率上升和研究活動擴展的推動。

由於可支配收入增加、醫療基礎設施改善以及人們對傷口管理的認識不斷提高，預計拉丁美洲、中東和非洲地區將出現增長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家主要疾病盛行率（2025/2025）
  • 主要產業趨勢：併購、業務合作
  • 產品供應：抗生物膜劑、主要參與者

第五章：全球抗生物膜劑市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品分類
    • 敷料
    • 軟膏/凝膠
    • 粉劑
  • 市場分析、洞察與預測：依分子分類
    • 銀
    • 碘
    • 蜂蜜
    • 其他
  • 市場分析、洞察與預測：依傷口類型分類
    • 慢性傷口
    • 急性傷口
  • 市場分析、洞察與預測：依最終用戶分類
    • 醫院
    • 傷口診所
    • 家庭醫療保健
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北部美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美抗生物膜劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲抗生物膜劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家

第八章 亞太地區抗生物膜劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲抗生物膜劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲抗生物膜劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家
    • 南亞非洲
    • 中東和非洲其他地區

第11章 競爭分析

  • 世界市場佔有率分析(2025年)
  • 企業簡介
    • Convatec Inc.
    • Smith+Nephew
    • Coloplast A/S
    • Solventum
    • Molnlycke AB
    • URGO MEDICAL
    • Imbed Biosciences
Product Code: FBI113668

Growth Factors of anti-biofilm agents Market

The global anti-biofilm agents market is witnessing steady growth, driven by the rising prevalence of acute and chronic wounds and the increasing burden of biofilm-associated infections. According to Fortune Business Insights, the global anti-biofilm agents market was valued at USD 1.5 billion in 2025. The market is projected to grow from USD 1.64 billion in 2026 to USD 3.21 billion by 2034, exhibiting a CAGR of 8.79% during the forecast period. North America dominated the market with a share of 36.49% in 2025, supported by advanced wound care infrastructure and higher awareness of biofilm management.

Anti-biofilm agents are products designed to prevent, disrupt, or manage biofilms, which are structured communities of microorganisms embedded within a self-produced matrix. Biofilms are commonly found in chronic wounds and significantly delay healing by increasing resistance to antibiotics and immune responses. According to data published by MDPI in 2024, biofilm formation occurs in approximately 60% of chronic wounds and 10% of acute wounds, highlighting the growing clinical need for effective anti-biofilm solutions.

Market Dynamics

Market Drivers

The increasing prevalence of acute and chronic wounds is a primary driver of market growth. Conditions such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, surgical wounds, and burn injuries are associated with a high risk of biofilm formation. For instance, data published by the National Center for Biotechnology Information in 2023 reported that the global prevalence of diabetic foot ulcers is around 6.3%. Additionally, hospital-acquired pressure ulcers remain a concern, with studies estimating an incidence of 8.7% among hospitalized patients in the U.K. These trends are driving the demand for advanced wound care and anti-biofilm products.

Market Restraints

Limited diagnosis and treatment rates in developing countries are restraining market growth. Delayed referrals, lack of clinical expertise, insufficient awareness, and absence of standardized guidelines often result in delayed diagnosis of chronic wounds. Studies published in 2023 reported delays ranging from 15 to 126 days from symptom onset to specialist assessment in patients with diabetic foot ulcers. These delays reduce timely adoption of anti-biofilm agents, particularly in emerging markets such as India, China, and Brazil.

Market Opportunities

Growing research and development activities among key players present significant growth opportunities. Companies are investing heavily in clinical trials and product innovation to introduce advanced dressings, gels, and powders with enhanced anti-biofilm properties. For example, in May 2024, Convatec Inc. reported positive clinical outcomes for its AQUACEL Ag+ Extra dressing in managing venous leg ulcers. Increasing government initiatives to improve wound care awareness further support market expansion.

Market Challenges

Limited adherence to biofilm prevention and management guidelines remains a challenge, particularly in developing regions. Low awareness among healthcare providers and patients leads to improper wound care practices, increasing the prevalence of biofilms. Additionally, the high cost of advanced anti-biofilm products restricts their adoption in cost-sensitive healthcare systems.

Anti-Biofilm Agents Market Trends

The introduction of novel anti-biofilm products is a key market trend. Researchers are increasingly exploring nanotechnology, nano-drug delivery systems, and antimicrobial nanoparticles such as silver and zinc oxide to improve biofilm penetration and disruption. Clinical studies evaluating these advanced technologies are expected to enhance product efficacy and boost demand during the forecast period.

Segmentation Analysis

By product, dressings dominated the market, accounting for 67.86% share in 2026, driven by their effectiveness in preventing bacterial contamination and managing biofilms.

By molecule, the silver segment led the market with a 47.62% share in 2026, owing to its broad-spectrum antimicrobial activity.

By wound type, chronic wounds accounted for 68.15% of the market in 2026, supported by the high prevalence of diabetic foot ulcers and pressure ulcers.

By end user, hospitals dominated with a 43.12% share in 2026, reflecting higher hospitalization rates and access to advanced wound care solutions.

Regional Outlook

North America led the market with a valuation of USD 0.55 billion in 2025 and USD 0.59 billion in 2026, supported by strong healthcare expenditure and product innovation.

Europe is expected to grow steadily due to established healthcare systems and rising awareness.

Asia Pacific is projected to register the fastest growth, driven by increasing wound prevalence and expanding research activities.

Latin America and the Middle East & Africa are expected to grow due to rising disposable incomes, healthcare infrastructure development, and increasing awareness of wound management.

Competitive Landscape

The market is moderately consolidated, with key players such as Smith+Nephew, Convatec Inc., and Coloplast A/S holding significant shares. These companies focus on product launches, clinical research, collaborations, and geographic expansion to strengthen their market position. Other notable players include Molnlycke AB, URGO MEDICAL, Solventum, and Imbed Biosciences.

Conclusion

The global anti-biofilm agents market is set for consistent growth over the forecast period, driven by the rising prevalence of chronic and acute wounds, increasing awareness of biofilm-associated complications, and continuous advancements in wound care technologies. With the market valued at USD 1.5 billion in 2025, projected to grow to USD 1.64 billion in 2026 and reach USD 3.21 billion by 2034, sustained R&D investments, innovation in antimicrobial technologies, and expanding healthcare infrastructure are expected to support long-term market expansion despite challenges related to cost, awareness, and guideline adherence.

Segmentation

By Product

  • Dressings
  • Ointments / Gels
  • Powders

By Molecule

  • Silver
  • Iodine
  • Honey
  • Others

By Wound Type

  • Chronic Wounds
  • Acute Wounds

By End User

  • Hospitals
  • Wound Clinics
  • Home Care Settings
  • Others

By Region

  • North America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, Key Countries, 2025/2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.3. Detailed Product Offerings: Anti-biofilm Agents, Key Players

5. Global Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Dressings
    • 5.1.2. Ointments / Gels
    • 5.1.3. Powders
  • 5.2. Market Analysis, Insights and Forecast - By Molecule
    • 5.2.1. Silver
    • 5.2.2. Iodine
    • 5.2.3. Honey
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Wound Type
    • 5.3.1. Chronic Wounds
    • 5.3.2. Acute Wounds
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals
    • 5.4.2. Wound Clinics
    • 5.4.3. Homecare Settings
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Dressings
    • 6.1.2. Ointments / Gels
    • 6.1.3. Powders
  • 6.2. Market Analysis, Insights and Forecast - By Molecule
    • 6.2.1. Silver
    • 6.2.2. Iodine
    • 6.2.3. Honey
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Wound Type
    • 6.3.1. Chronic Wounds
    • 6.3.2. Acute Wounds
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals
    • 6.4.2. Wound Clinics
    • 6.4.3. Homecare Settings
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Dressings
    • 7.1.2. Ointments / Gels
    • 7.1.3. Powders
  • 7.2. Market Analysis, Insights and Forecast - By Molecule
    • 7.2.1. Silver
    • 7.2.2. Iodine
    • 7.2.3. Honey
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Wound Type
    • 7.3.1. Chronic Wounds
    • 7.3.2. Acute Wounds
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals
    • 7.4.2. Wound Clinics
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Russia
    • 7.5.7. Rest of Europe

8. Asia Pacific Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Dressings
    • 8.1.2. Ointments / Gels
    • 8.1.3. Powders
  • 8.2. Market Analysis, Insights and Forecast - By Molecule
    • 8.2.1. Silver
    • 8.2.2. Iodine
    • 8.2.3. Honey
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Wound Type
    • 8.3.1. Chronic Wounds
    • 8.3.2. Acute Wounds
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals
    • 8.4.2. Wound Clinics
    • 8.4.3. Homecare Settings
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. China
    • 8.5.2. India
    • 8.5.3. Japan
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Dressings
    • 9.1.2. Ointments / Gels
    • 9.1.3. Powders
  • 9.2. Market Analysis, Insights and Forecast - By Molecule
    • 9.2.1. Silver
    • 9.2.2. Iodine
    • 9.2.3. Honey
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Wound Type
    • 9.3.1. Chronic Wounds
    • 9.3.2. Acute Wounds
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals
    • 9.4.2. Wound Clinics
    • 9.4.3. Homecare Settings
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle Est & Africa Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Dressings
    • 10.1.2. Ointments / Gels
    • 10.1.3. Powders
  • 10.2. Market Analysis, Insights and Forecast - By Molecule
    • 10.2.1. Silver
    • 10.2.2. Iodine
    • 10.2.3. Honey
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Wound Type
    • 10.3.1. Chronic Wounds
    • 10.3.2. Acute Wounds
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals
    • 10.4.2. Wound Clinics
    • 10.4.3. Homecare Settings
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Convatec Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Smith+Nephew
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Coloplast A/S
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Solventum
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Molnlycke AB
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. URGO MEDICAL
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Imbed Biosciences
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 3: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 4: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 5: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 7: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 8: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 9: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 10: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 13: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 14: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 15: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 17: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 18: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 19: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 23: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 24: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 25: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 27: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2021-2034
  • Table 28: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2021-2034
  • Table 29: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 30: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Anti-biofilm Agents Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Anti-biofilm Agents Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Anti-biofilm Agents Segmental Opportunity Index, By Product, 2025
  • Figure 4: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Product, 2025 & 2034
  • Figure 5: Global Anti-biofilm Agents Market Value Share (%), by Molecule, 2025 & 2034
  • Figure 6: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2025
  • Figure 7: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2025
  • Figure 8: Global Anti-biofilm Agents Market Value Share (%), by Wound Type, 2025 & 2034
  • Figure 9: Global Anti-biofilm Agents Segmental Opportunity Index, By Wound Type, 2025
  • Figure 10: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Wound Type, 2025 & 2034
  • Figure 11: Global Anti-biofilm Agents Market Value Share (%), by End User, 2025 & 2034
  • Figure 12: Global Anti-biofilm Agents Segmental Opportunity Index, By End User, 2025
  • Figure 13: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By End User, 2025 & 2034
  • Figure 14: Global Anti-biofilm Agents Market Value Share (%), by Region, 2025 & 2034
  • Figure 15: Global Anti-biofilm Agents Segmental Opportunity Index, By Region, 2025
  • Figure 16: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Region, 2025 & 2034
  • Figure 17: North America Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: North America Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 19: North America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 20: North America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 21: North America Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 22: North America Anti-biofilm Agents Market Value (USD billion), By Country, 2025 & 2034
  • Figure 23: Europe Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 24: Europe Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 25: Europe Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 26: Europe Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 27: Europe Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 28: Europe Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 30: Asia Pacific Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 31: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 32: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 33: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 35: Latin America Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 36: Latin America Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 37: Latin America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 38: Latin America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 39: Latin America Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 40: Latin America Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 41: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Product, 2025 & 2034
  • Figure 42: Middle East & Africa Anti-biofilm Agents Market Value Share (%), by Product, 2025
  • Figure 43: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Molecule, 2025 & 2034
  • Figure 44: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2025 & 2034
  • Figure 45: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by End User, 2025 & 2034
  • Figure 46: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 47: Global Anti-biofilm Agents Market Share (%), By Company, 2025